NEW YORK, Nov. 7, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds sellers of ordinary shares, including those that sold into the Merger of Sina Corporation (NASDAQ: SINA) between October 13, 2020 and March 22, 2021, both dates inclusive (the “Class Period”), of the important November 18, 2025 lead… Continue reading SINA Investors Have Opportunity to Lead Sina Corporation Securities Fraud Lawsuit
Category: Newswire
NX Investors Have Opportunity to Lead Quanex Building Products Corporation Securities Fraud Lawsuit
NEW YORK, Nov. 7, 2025 /PRNewswire/ — Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Quanex Building Products Corporation (NYSE: NX) between December 12, 2024 and September 5, 2025, both dates inclusive (the “Class Period”), of the important November 18, 2025 lead plaintiff deadline. So what: If you purchased… Continue reading NX Investors Have Opportunity to Lead Quanex Building Products Corporation Securities Fraud Lawsuit
Molina Healthcare, Inc. (MOH) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
LOS ANGELES, Nov. 7, 2025 /PRNewswire/ — The Law Offices of Frank R. Cruz announces that investors with losses related to Molina Healthcare, Inc. (“Molina” or the “Company”) (NYSE: MOH) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN MOLINA HEALTHCARE, INC. (MOH), CLICK HERE BEFORE DECEMBER… Continue reading Molina Healthcare, Inc. (MOH) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
WPP plc (WPP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
LOS ANGELES, Nov. 7, 2025 /PRNewswire/ — The Law Offices of Frank R. Cruz announces that investors with losses related to WPP plc (“WPP” or the “Company”) (NYSE: WPP) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN WPP PLC (WPP), CLICK HERE BEFORE DECEMBER… Continue reading WPP plc (WPP) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
LOS ANGELES, Nov. 7, 2025 /PRNewswire/ — The Law Offices of Frank R. Cruz announces that investors with losses related to MoonLake Immunotherapeutics (“MoonLake” or the “Company”) (NASDAQ: MLTX) have opportunity to lead the securities fraud class action lawsuit. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN MOONLAKE (MLTX) CLICK HERE BEFORE DECEMBER 15, 2025… Continue reading MoonLake Immunotherapeutics (MLTX) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
KMX Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against CarMax, Inc. With Expanded Class Period
RADNOR, Pa., Nov. 7, 2025 /PRNewswire/ — The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that an amended securities class action lawsuit has been filed against CarMax, Inc. (“CarMax”) (NYSE: KMX) which expands the class period to include those who purchased or otherwise acquired CarMax securities between June 20, 2025, and November 5,… Continue reading KMX Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Securities Fraud Class Action Lawsuit Filed Against CarMax, Inc. With Expanded Class Period
SLNO INVESTIGATION ALERT: Investigation Launched into Soleno Therapeutics, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm
SAN DIEGO, Nov. 7, 2025 /PRNewswire/ — Robbins Geller Rudman & Dowd LLP is investigating potential violations of U.S. federal securities laws involving Soleno Therapeutics, Inc. (NASDAQ: SLNO) focused on whether Soleno and certain of its top executives made false and/or misleading statements and/or failed to disclose material information to investors. If you have information… Continue reading SLNO INVESTIGATION ALERT: Investigation Launched into Soleno Therapeutics, Inc., Attorneys Encourage Investors and Potential Witnesses to Contact Law Firm
U.S. FDA approves KYGEVVI™ (doxecitine and doxribtimine), the first and only treatment for adults and children living with thymidine kinase 2 deficiency (TK2d)
Approved indication: KYGEVVI™ (doxecitine and doxribtimine) powder for oral solution (2g/2g) is approved for the treatment of thymidine kinase 2 deficiency (TK2d) in adults and pediatric patients with an age of symptom onset on or before 12 years.1 Survival benefit: Treatment reduced the overall risk of death from the start of treatment by approximately 86% (95% CI:… Continue reading U.S. FDA approves KYGEVVI™ (doxecitine and doxribtimine), the first and only treatment for adults and children living with thymidine kinase 2 deficiency (TK2d)
MSC SEASCAPE ARRIVES IN GALVESTON AHEAD OF MSC CRUISES’ FIRST-EVER SAILINGS FROM NEW TEXAS HOMEPORT
MSC Seascape docks at The Port of Galveston’s new state-of-the-art Cruise Terminal 16 ahead of setting sail on first itinerary from Texas on Sunday, November 9 MSC Cruises and NBC’s TODAY unveil new “Read With Jenna” installations aboard MSC Seascape Ship will bring MSC Cruises’ European style and American comfort to a brand-new U.S. market… Continue reading MSC SEASCAPE ARRIVES IN GALVESTON AHEAD OF MSC CRUISES’ FIRST-EVER SAILINGS FROM NEW TEXAS HOMEPORT
Erfolgreicher Abschluss der 138. Canton Fair
GUANGZHOU, China, 8. November 2025 /PRNewswire/ — Die 138. Canton Fair ist am 4. November erfolgreich zu Ende gegangen. Die Messe stellte neue historische Rekorde in Bezug auf mehrere Indikatoren auf, darunter die Anwesenheit von Einkäufern aus Übersee und innovative, intelligente und grüne Produkte. Continue Reading image_969985_37378971 Insgesamt nahmen über 310.000 Käufer aus 223 Ländern und Regionen… Continue reading Erfolgreicher Abschluss der 138. Canton Fair